Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106764994 | 10676499 | 4 | F | 20111025 | 20160706 | 20141226 | 20160802 | EXP | US-ROCHE-1026502 | ROCHE | 60.40 | YR | F | Y | 94.10000 | KG | 20160802 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106764994 | 10676499 | 1 | PS | Vismodegib | VISMODEGIB | 1 | Oral | CYCLES 1-5+ | 203388 | 150 | MG | QD | |||||||
| 106764994 | 10676499 | 2 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 200 MG OVER 2 HOURS ON DAYS 1-3; CYCLES 1-4 | 0 | 100 | MG/M**2 | ||||||||
| 106764994 | 10676499 | 3 | SS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | 152 MG OVER 2 HOURS ON DAY 1; CYCLES 1-4 | 0 | 75 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106764994 | 10676499 | 1 | Small cell lung cancer |
| 106764994 | 10676499 | 2 | Small cell lung cancer |
| 106764994 | 10676499 | 3 | Small cell lung cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106764994 | 10676499 | OT |
| 106764994 | 10676499 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106764994 | 10676499 | Cough | |
| 106764994 | 10676499 | Diarrhoea | |
| 106764994 | 10676499 | Dyspnoea | |
| 106764994 | 10676499 | Fatigue | |
| 106764994 | 10676499 | Hyperglycaemia | |
| 106764994 | 10676499 | Hypertension | |
| 106764994 | 10676499 | Hypokalaemia | |
| 106764994 | 10676499 | Hypoxia | |
| 106764994 | 10676499 | Neutrophil count decreased | |
| 106764994 | 10676499 | Non-cardiac chest pain | |
| 106764994 | 10676499 | Pain | |
| 106764994 | 10676499 | Respiratory failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106764994 | 10676499 | 1 | 20110629 | 20111023 | 0 | |
| 106764994 | 10676499 | 2 | 20110629 | 20110902 | 0 | |
| 106764994 | 10676499 | 3 | 20110629 | 20110831 | 0 |